 Table of 
Three-dimensional model design
For the initial tertiary structure of the RNA triplexes (mRNA E2F1 /miRNA 1 /miRNA 2 ) as well as their two intrinsic RNA duplexes (mRNA E2F1 /miRNA 1 and mRNA E2F1 /miRNA 2 ), we used the RNAComposer web server (1), a tool for constructing large RNA 3D structures based on user defined secondary structure information. We used the secondary structures of the RNA complexes and received initial 3D structures in the form of long concatenated mRNA and miRNA units. Then, we used the Build and Edit Nucleic Acid tool in BIOVIA ® Discovery Studio 4.5 to separate RNA units present in the complex as per the procedure described in our previous publication (2) . To further optimize the 3D structures of RNA complexes and to remove steric overlap that produces bad contacts we used Smart Minimizer protocol available in BIOVIA ® Discovery Studio 4.5 after assigning the charmm27 force field, a superset of the charmm22 force field with the additional coverage for nucleic acids (3, 4) .
The Smart Minimizer protocol was set for a maximum run of 5000 steps with the Minimization RMS Gradient tolerance of 0.1 kcal/(mol x Å) to terminate the minimization routine in case the average gradient is less than or equal to the set cut-off. After the structural optimization, we calculated initial potential energies of all the RNA complexes using the Calculate Energy protocol in BIOVIA ® DS 4.5. Such energy profile indicates the stability of the RNA complexes in the 3D model.
Molecular dynamics simulations
Molecular dynamics simulations were carried out using the Standard Dynamics Cascade protocol in BIOVIA ® DS 4.5 in four steps: (i) minimization; (ii) heating and cooling; (ii) equilibrium run;
and (iv) production run, for all the potential cooperating miRNAs complexed with the 3' UTR of E2F1. Minimization of the 3D structures to find the most stable confirmations of the RNA complexes was carried out using the Steepest Descent algorithm followed by the Conjugate Gradient algorithm for 2000 steps each. In case the structure was not minimized, the protocol was repeated iteratively. After the minimization step, all the complexes were subjected to gradual heating from 50 K to 300 K by rescaling the velocity of each atom in a total of 10,000 steps with the time interval of 1 fs. The initial velocity was assigned according to a Maxwell-Boltzmann distribution corresponding to a temperature close to 50 K. In the equilibration phase the system was stabilized around 300 K temperature by periodically reassigning the velocities to each atom employing the LeapFrog Verlet algorithm with time steps of 1 fs in 50,000 steps. After heating, RNA complexes were subjected to the production run at constant-temperature, constant-volume ensemble (NVT) for initially 500 ps. The production run was further extended in blocks of 100 ps for those RNA complexes where at least one miRNA was still attached to E2F1 mRNA.
Trajectories of the atoms were recorded at each 1,000 steps to investigate intermolecular H-bonds during the course of simulation. All simulation steps were carried out in the Generalized Born with simple SWitching (GBSW) implicit solvent model with dielectric constant 80 for better approximation of the solvent effect on the RNA triplex. We have deliberately used the GBSW implicit solvent model to save computational cost, which arises due to the long chain-like structures of RNA complexes that require a large number of solvent molecules in case of explicit solvent models. The SHAKE algorithm constraint was set to true for all the covalent bonds involving hydrogen atoms at their respective distances from the charmm27 force field parameters.
Mathematical modelling of E2F1 regulation by miRNAs

Kinetic modelling of E2F1 repression efficiency in paired miRNA regulation
To elaborate on the mechanism by which E2F1 is repressed by cooperative miRNA pairs, we developed a kinetic model of ordinary differential equations.
The model accounts for the formation of two RNA duplexes (duplex) and one RNA Table S1 and S2. ] to imitate the down-and upregulation of miRNA expression.
We sampled 121*121 combinations of characteristic miRNA expression profiles in this interval and calculated the corresponding steady states of E2F1 (SS E2F1 ( , )). The gain of E2F1 repression efficiency for representative miRNA expression levels was calculated using the following equations and indicated as reference points in Figure 3 : indicates the steady state of E2F1 when both miRNAs are moderately upregulated.
To Finally, we simulated the model and compared the steady states of E2F1 and mE2F1 with the experimental data that show the expression levels of E2F1 mRNA and protein in these scenarios ( Figure 4D ). Both the simulation results and the experimental data were normalized to the scenario in which a scrambled miRNA was transfected.
Kinetic modelling of chemoresistance and miRNA cooperativity
To simulate the effect of miR-205-5p and miR-342-3p on the response of tumour cells to drug treatment, we integrated the cooperative regulation of E2F1 by the two miRNAs into our previously published kinetic model of E2F1-mediated chemoresistance (Vera et al. 2013 ). The kinetic model is composed of thirteen ordinary differential equations, which account for the temporal dynamics of the regulatory network, whose activation is triggered after anticancer drug administration and modulates a phenotypic response in a population of tumour cells. The model has the following structure:
Time dependent variables in the model account for the levels of: transcriptionally active Table S4 . Next, the network dynamics were simulated with the model, and protein expression levels, miR-205-5p levels, and the size of the tumour cell population were calculated in two different scenarios:
a) The non-drug stimulation condition is modelled by configuring specific model parameters as follows: GxD=0, DS=0 and GWF=1;
b) The genotoxic drug administration is modelled by configuring specific model parameters as follows: GxD=1, DS=1 and GWF=0, as such kind of drug can cause DNA damage that can lead to cell cycle arrest and thus preventing tumour cell from proliferating (6). 
RNA isolation and qPCR
RNA was extracted using the NucleoSpin RNA Kit (MACHEREY-NAGEL). (Figure 4) , we assumed that the repression efficiency of E2F1 by miR-342-3p is similar to miR-205-5p and that their cooperative repression effects on E2F1 doubles compared to their individual repression. As the degradation rate of miR-324-3p is unknown we used the same value as miR-205-5p, assuming that it is a stable molecule based on the conclusion in (9) . $ Those parameters are sampled within the specified intervals for simulations. # Those parameters are binary and are set to 0 or 1 for corresponding biological conditions. ^T his parameter is set to 0 as in this study the effect of cytostatic drug is not considered. and m <miR1, miR2, miR1+miR2> were estimated by fitting the median-effect function to the experimental data (i.e. D <miR1,miR2, miR1+miR2> and their corresponding fa), and the linear correlation r <miR1, miR2, miR1+miR2> signifies the goodness of fit of the experimental data with the function (11). The dose-reduction index (DRI) is a measure of how many fold the dose of each miRNA in a synergistic combination may be reduced at a given effect level (11). The index is calculated using the equation , where is the actual dose of a miRNA used in the combined miRNA treatment, and is the estimated dose of the miRNA that is needed to achieve the same effect, i.e. fa miR , in the single miRNA treatment. If the value of DRI <miR1,miR2> is greater than 1, it indicates a dose reduction of a miRNA for repressing E2F1. miR1: miR-205; miR2: miR-342. The table shows the doses (D) of miRNAs used for calculating the combination indexes of the combined miRNA treatments in H1299 cells using different concentrations of cisplatin (20 µM or 40 µM). The detailed description of the parameters can be found in Table S5 . miR1: miR-205; miR2: miR-342. 
Supplementary table and figure
